Some Massachusetts Biotechs Get Caught in the Squeeze
Published On: July 23rd, 2009
It’s no secret that the biotech industry has been hurting during the economic downturn as as investor dollars slowed to a trickle. As of March, 120 out of 360 publicly traded biotechs had less than six months of cash left, and 10 had filed for bankruptcy since November.
The Boston Globe reports this morning that in the past week, two more folded in Massachusetts — one of the hubs of biotech activity.
Biopure, which was trying to develop a human blood substitute, filed for Chapter 11 bankruptcy protection last week. Yesterday, Epix Pharmaceuticals said it was liquidating its assets after failing to secure additional financing or an acquirer. Epix had been collaborating with GlaxoSmithKline on an Alzheimer’s drug.
There are still some biotechs that aren’t having trouble with funding. But biotech analysts say that companies with products already on the market or very promising late-stage compounds tend to have much less trouble.
Go here to read the rest:
Some Massachusetts Biotechs Get Caught in the Squeeze
STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!
The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.
Did you know:
Colorectal: 47.4 per 100,000 people per year
2009 -